C4 Therapeutics


C4 Therapeutics (C4T) is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.

Industries

Employees

51-200

Links


Org chart

Andrew Hirsch
President & CEO
Collapse
Scott Boyle
Chief Business Officer
Len Reyno
Chief Medical Officer
Kelly Schick
Chief People Officer
Jolie Siegel
Chief Legal Officer
Kendra Adams
SVP, Communications & IR
Mary Christian
SVP, Regulatory
Mayra Reyes-Armour
VP, Technical Operations
Robert Bruno
Vice President, CMC And Supply Chain
Adrian Bignami
Vice President Of Finance, Business Planning And Analysis
Anna G. Maione
Director, Portfolio & Program Management
Damir K.
Director Of Information Technology
Brent Appleton
Senior Director
Jeffrey Simard
Senior Director
Mayra B. Reyes-Armour
Senior Vice President, Technical Operations, Quality & Facilities
Christopher Nasveschuk
Senior Vice President, Chemistry
Prasoon Chaturvedi
Senior Director, Head Of DMPK
Douglas Orsi
Principal Scientist 1
Hope Flaxman
Senior Research Scientist
Oscar Ingham
Senior Research Scientist - Cheminformatics

Board & advisors

Ron Cooper
Chairman
Ken Anderson
Director
Bruce Downey
Director
Donna Grogan
Director
Laura Bessen
Director
Ross Levine
Clinical Advisory Board Member
Chris Bowden
Clinical Advisory Board Member
Scott Armstrong
Scientific Advisory Board Member
Beni Wolf
Clinical Advisory Board Member
Randi Isaacs
Clinical Advisory Board Member
Ryan B. Corcoran
Scientific Advisory Board Member
Nathanael Gray
Scientific Advisory Board Member
Christopher Kirk
Scientific Advisory Board Member